Navigation Links
Groupe Athena, Inc. Reports Record First Quarter Revenues, Adoption Of IFRS Accounting Standard In Anticipation Of Applying For Listing On The NASDAQ Bulletin Board
Date:11/14/2012

positioned to help them get their products approved by the FDA for sales in the US. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation. With recent additions to equipment, the company will continue to take on additional contracts and continue to anticipate further growth.

About Groupe Athena, Inc.

Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.

The company has a research and marketing facility in India that currently employs 17 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com

For more information contact:
Paul Cornell
Corporate Shareholder Relations, Inc.
pcornell@totalpublicrelations.com

Safe Harbor Statement
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of simi
'/>"/>

SOURCE Groupe Athena, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
2. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
3. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
4. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
5. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
6. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
7. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
8. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
9. Luminex Corporation Reports First Quarter 2012 Results
10. Hospira Reports First-Quarter 2012 Results
11. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... BRAINTREE, Mass. , May 23, 2013  Haemonetics Corporation ... Chris Lindop , CFO & EVP-Business Development, will present ... Care Conference in Boston, MA on ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... The SCOOTER Store today announced a major milestone, saying it has ... power wheelchair to Earvin Thompson of Houston, Texas . ... leading provider of power mobility equipment, will enjoy more freedom and independence ... , ...
... GRONINGEN, The Netherlands , June 22, 2010 ... announced this week that in collaboration,with the University ... for the treatment of inhalation anthrax. In a rabbit ... time to treatment (48h post,infection) with a combination of ...
Cached Medicine Technology:The SCOOTER Store Marks Half-Millionth Life Changed 2The SCOOTER Store Marks Half-Millionth Life Changed 3The SCOOTER Store Marks Half-Millionth Life Changed 4Survival Rate Up to 100% for Late Stage Treatment of Anthrax Infections 2
(Date:5/24/2013)... -- Drugs commonly used to treat glaucoma may cause ... with vision, according to a new study. The ... to reduce eye pressure, have already been shown to ... the researchers said, suggesting that the new findings could ... should be conservative when prescribing these drugs, the researchers ...
(Date:5/24/2013)... Lake City, Utah (PRWEB) May 24, 2013 ... 2.0 , with exciting new enhancements for instructors and ... students stay more focused through personalize learning plan templates, ... new AnatomyOne release provides 500 new assessment questions, 5,000 ... and review notes. , AnatomyOne 2.0 is ...
(Date:5/24/2013)... BestSatelliteProviders.com the online satellite TV and ... compare the features and services offered by leading ... the rankings of the best rural Internet ... on their website. , BestSatelliteProviders.com – ... Matthews, the spokesperson for BestSatelliteProviders.com, “When consumers were ...
(Date:5/24/2013)... to the National Institutes of Health, Stevens Johnson Syndrome (SJS) ... the skin and mucous membranes. SJS occurs most commonly ... (i). In the early stages SJS presents flu-like symptoms, ... it affects the mucous membranes such as the eyes, mouth ... eye causes conjunctivitis (pink eye). Inflammation of the mouth ...
(Date:5/24/2013)... News) -- The number of U.S. patients admitted ... in an emergency room has increased by nearly ... study, conducted by researchers at the George Washington ... in Washington, D.C., found that patients wait five ... being admitted to the ICU. The researchers said ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
... The Diversified Agency Services (DAS),unit of Omnicom ... position of,Executive Vice President and Director of ... will direct the client-centric and,brand-centric teams within ... resource of specialist agencies that support,the strategic ...
... is ,good news, for postmenopausal women taking anastrozole ... to previous study results, the cancer prevention drug ... cognitive performance, a new study found. , ... tamoxifen in preventing breast cancer recurrence in postmenopausal ...
... WINSTON-SALEM, N.C. Scientists at Wake Forest University School ... cancer gene called HNF1B have found a second independent ... increasing the number of genetic variants that may ... comparing the newly-discovered site with a previously discovered site ...
... , The guidelines are developed through a rigorous ... the field and a review committee of 21 international ... the first time both acute and chronic heart failure. ... patients with acute heart failure often develop chronic problems ...
... largest multi-institutional study to date examining the impact of ... individuals with suspected recurrent colorectal cancer, researchers found that ... patients, according to an article in the September issue ... The study was conducted at four sites throughout Australia ...
... Dr. Charmaine Yoest,President and CEO of Americans United ... that the daughter of McCain running mate,Sarah Palin is ... know this situation is not the ideal,Sarah Palin wished ... life,s,challenges is the true testament to our character. The ...
Cached Medicine News:Health News:Sharon Callahan Joins Diversified Agency Services Unit of Omnicom Group 2Health News:Breast Cancer Drug Not Tied to Cognitive Decline: Study 2Health News:Scientists find second site for prostate cancer gene 2Health News:PET scans lead to treatment changes in majority of colorectal cancer patients 2
This ENDOLOOP suture has a suture type - 0 PDSII and a 1.5 inch diameter....
This ENDOLOOP suture has a suture type - 0 Coated VICRYL and a 1.5 inch diameter....
... bring modern Data Management capabilities to the ... wide range of settings and definable options, ... the operator for identification, lot numbers, quality ... This data can then be transmitted to ...
Bartels Clostridium difficile Toxin A Enzyme Immunoassay (EIA) is intended for the qualitative detection of Clostridium difficile Toxin A in human faecal specimens as an aid in the diagnosis of Clost...
Medicine Products: